Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rebeca Ocampo"'
Autor:
Jaimie Z. Shing, Carolina Porras, Maísa Pinheiro, Rolando Herrero, Allan Hildesheim, Danping Liu, Mitchell H. Gail, Byron Romero, John T. Schiller, Michael Zúñiga, Sambit Mishra, Laurie Burdette, Kristine Jones, John Schussler, Rebeca Ocampo, Jianwen Fang, Zhiwei Liu, Douglas R. Lowy, Sabrina H. Tsang, Ana Cecilia Rodríguez, Mark Schiffman, Cameron B. Haas, Loretto J. Carvajal, Jalen R. Brown, Aimée R. Kreimer, Lisa Mirabello, Costa Rica HPV Vaccine Trial (CVT) Group
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-11 (2024)
Abstract The AS04-adjuvanted human papillomavirus (HPV)16/18 vaccine, an L1-based vaccine, provides strong vaccine efficacy (VE) against vaccine-targeted type infections, and partial cross-protection to phylogenetically-related types, which may be af
Externí odkaz:
https://doaj.org/article/34f39d3bc9f746019ec00687f85c2a66
Autor:
Allan Hildesheim, Tim Waterboer, Julia Butt, Mitchell H Gail, Alejandro Calderón, Rolando Herrero, Carolina Porras, Bernal Cortes, Viviana Loría, Amada Aparicio, Gloriana Barrientos, Daniela Retana, Kaiyuan Sun, Rebeca Ocampo, D. Rebecca Prevots, Michael Zúñiga, Roy Wong-McClure, Melvin Morera, Marco Binder, Arturo Abdelnour, Ruth M Pfeiffer, Cristina Barboza Solís, Romain Fantin, Juan Carlos Vanegas, Rachel Mercado, Carlos Ávila
Publikováno v:
BMJ Open, Vol 13, Iss 12 (2023)
Purpose The RESPIRA cohort aims to describe the nature, magnitude, time course and efficacy of the immune response to SARS-CoV-2 infection and vaccination, population prevalence, and household transmission of COVID-19.Participants From November 2020,
Externí odkaz:
https://doaj.org/article/7a40c3b8191647a2b1b163cf7a27a64b
Autor:
Loretto J Carvajal, Rolando Herrero, María M. Angulo, John Schussler, Carolina Porras, Rebeca Ocampo, Bernal Cortés, Viviana Loría, Hariane Castrillo, Byron Romero, Gloriana Barrientos, Karla Coronado, Carlos Ávila, Allan Hildesheim, Ana C. Rodríguez, Silvia E. Jiménez, Aimée R. Kreimer, Mónica S Sierra
Publikováno v:
Salud Pública de México. 65:253-264
Objetivo. Estimar la prevalencia e identificar determinantes de la infección por el virus del papiloma humano (VPH) en mujeres jóvenes (18-25 años). Material y métodos. Se analizaron datos de 5 871 mujeres sexualmente activas a quienes se les rea
Autor:
Feixue Wei, Ningshao Xia, Rebeca Ocampo, Marc T Goodman, Nancy A Hessol, Beatriz Grinsztejn, Ana P Ortiz, Fanghui Zhao, Erna M Kojic, Rupert Kaul, Isabelle Heard, Imran O Morhason-Bello, Anna-Barbara Moscicki, Alexandra de Pokomandy, Joel M Palefsky, Luana L S Rodrigues, Racheal S Dube Mandishora, Reshmie A Ramautarsing, Silvia Franceschi, Sheela V Godbole, Fernanda K Tso, Lynette J Menezes, Chunqing Lin, Gary M Clifford
Publikováno v:
The Journal of infectious diseases, vol 227, iss 4
Background Age-specific data on anal, and corresponding cervical, human papillomavirus (HPV) infection are needed to inform female anal cancer prevention. Methods We centrally reanalyzed individual-level data from 26 studies reporting HPV prevalence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8f5f2ce992936522dfd08eb265b2ecb
https://escholarship.org/uc/item/0mz5s7n0
https://escholarship.org/uc/item/0mz5s7n0
Autor:
Feixue, Wei, Ningshao, Xia, Rebeca, Ocampo, Marc T, Goodman, Nancy A, Hessol, Beatriz, Grinsztejn, Ana P, Ortiz, Fanghui, Zhao, Erna M, Kojic, Rupert, Kaul, Isabelle, Heard, Imran O, Morhason Bello, Anna-Barbara, Moscicki, Alexandra, de Pokomandy, Joel M, Palefsky, Luana L S, Rodrigues, Racheal S Dube, Mandishora, Reshmie A, Ramautarsing, Silvia, Franceschi, Sheela V, Godbole, Fernanda K, Tso, Lynette J, Menezes, Chunqing, Lin, Gary M, Clifford
Publikováno v:
J Infect Dis
BACKGROUND: Age-specific data on anal, and corresponding cervical, human papillomavirus (HPV) infection are needed to inform female anal cancer prevention. METHODS: We centrally reanalyzed individual-level data from 26 studies reporting HPV prevalenc
Autor:
Carolina Porras, Sabrina H Tsang, Rolando Herrero, Diego Guillén, Teresa M Darragh, Mark H Stoler, Allan Hildesheim, Sarah Wagner, Joseph Boland, Douglas R Lowy, John T Schiller, Mark Schiffman, John Schussler, Mitchell H Gail, Wim Quint, Rebeca Ocampo, Jorge Morales, Ana C Rodríguez, Shangying Hu, Joshua N Sampson, Aimée R Kreimer, Bernal Cortés, Paula González, Silvia E Jiménez, Ana Cecilia Rodríguez, Mark Sherman, Ligia A Pinto, Troy J Kemp, Mary K Sidawy, Leen-Jan Van Doorn, Linda Struijk, Joel M Palefsky
Publikováno v:
The Lancet. Oncology, vol 21, iss 12
Lancet Oncol
Lancet Oncol
Summary Background Oncogenic human papillomavirus (HPV) infections cause most cases of cervical cancer. Here, we report long-term follow-up results for the Costa Rica Vaccine Trial (publicly funded and initiated before licensure of the HPV vaccines),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b8dcc147dfff2c09ffcea3e410e35bd
https://escholarship.org/uc/item/9fr8c985
https://escholarship.org/uc/item/9fr8c985
Autor:
Mark Schiffman, Wim Quint, Allan Hildesheim, Rebeca Ocampo, Joel M. Palefsky, Teresa M. Darragh, Diego Guillén, Rolando Herrero, Mahboobeh Safaeian, Silvia Jimenez, Ana Cecilia Rodriguez, Aimée R. Kreimer, Douglas R. Lowy, Sholom Wacholder, Carolina Porras, John Schussler, Carlos Avila, Bernal Cortes, Paula Gonzalez, Loreto Carvajal, Hormuzd A. Katki, John T. Schiller, Mark H. Stoler, Brian Befano, Jorge Morales
Publikováno v:
Vaccine. 33:2141-2151
The Costa Rica Vaccine Trial (CVT) was a randomized clinical trial conducted between 2004 and 2010, which randomized 7466 women aged 18 to 25 to receive the bivalent HPV-16/18 vaccine or control Hepatitis-A vaccine. Participants were followed for 4 y